Inventor · disambiguated record
Carl F. Ware
Also filed as: WARE CARL · WARE CARL F
22 granted patents·7 pending applications·234 citations·filing 1995–2024
95Inventor score
Files withSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST8JOLLA INST ALLERGY IMMUNOLOG4WARE CARL F4BIOGEN INC3GRANGER STEVEN W2
Top patents by PatentIndex Score
29 records- 0192US7030080B2Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereofUNIV CALIFORNIA·Filed 2001·Granted Apr 18, 2006·37 cites·5 claims
- 0291US8058402B2Antagonistic human LIGHT-specific human monoclonal antibodiesGRANGER STEVEN W·Filed 2007·Granted Nov 15, 2011·22 cites·38 claims
- 0389US8974787B2Antagonistic human light-specific human monoclonal antibodiesKYOWA HAKKO KIRIN CO LTD·Filed 2013·Granted Mar 10, 2015·11 cites·20 claims
- 0488US7575745B2Ligand for herpes simplex virus entry mediator and methods of useJOLLA INST ALLERGY IMMUNOLOG·Filed 2006·Granted Aug 18, 2009·10 cites·7 claims
- 0587US8461307B2Antagonistic human LIGHT-specific human monoclonal antibodiesGRANGER STEVEN W·Filed 2011·Granted Jun 11, 2013·10 cites·28 claims
- 0685US9982023B2Compositions and methods for treating autoimmune and inflammatory disordersSANFORD BURNHAM MED RES INST·Filed 2012·Granted May 29, 2018·3 cites·28 claims
- 0783US5795964ALymphotoxin-beta and lymphotoxin-beta complexesBIOGEN INC·Filed 1995·Granted Aug 18, 1998·37 cites·11 claims
- 0883US5670149ALymphotoxin-β, Lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereofBIOGEN INC·Filed 1995·Granted Sep 23, 1997·38 cites·3 claims
- 0982US9771419B2Antagonistic human light-specific human monoclonal antibodiesKYOWA HAKKO KIRIN CO LTD·Filed 2015·Granted Sep 26, 2017·3 cites·18 claims
- 1081US10961297B2BTLA fusion protein agonists and uses thereofSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2016·Granted Mar 30, 2021·2 cites·5 claims
- 1178US10717765B2Compositions and methods for treating autoimmune and inflammatory disordersSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2018·Granted Jul 21, 2020·1 cites·21 claims
- 1278US9700606B2HVEM/BTLA, HVEM/CD 160 and HVEM/gD cis complexes and methods of useWARE CARL F·Filed 2009·Granted Jul 11, 2017·5 cites·26 claims
- 1378US8349320B2Compositions and methods for modulating responses mediated or associated with BTLA activityJOLLA INST ALLERGY IMMUNOLOG·Filed 2009·Granted Jan 8, 2013·9 cites·17 claims
- 1477US2024247047A1BTLA Fusion Protein Agonists and Uses ThereofSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2024·Application pending·0 cites
- 1576US5661004ALymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereofBIOGEN INC·Filed 1995·Granted Aug 26, 1997·42 cites·5 claims
- 1672US11352428B2Modulation of immune response using BTLA agonist antibodiesSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2016·Granted Jun 7, 2022·2 cites·7 claims
- 1770US11939367B2BTLA fusion protein agonists and uses thereofSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2021·Granted Mar 26, 2024·0 cites·17 claims
- 1869US11365221B2Compositions and methods for treating autoimmune and inflammatory disordersSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2020·Granted Jun 21, 2022·0 cites·10 claims
- 1964US8153123B2Method for restoring dendritic cell populationsWARE CARL F·Filed 2009·Granted Apr 10, 2012·2 cites·36 claims
- 2063US10759863B2Modulation of γδ T cellsSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2014·Granted Sep 1, 2020·0 cites·16 claims
- 2162US2022380468A1Modulation of immune response using btla agonist antibodiesSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2022·Application pending·0 cites
- 2260US2010129389A1Methods of modulating hvem, btla and cd160 cis complex response or signaling activity with soluble light polypeptide sequencesJOLLA INST ALLERGY IMMUNOLOG·Filed 2009·Application pending·0 cites
- 2357US10220081B2Methods of modulating HVEM, BTLA and CD160 cis complex response or signaling activity with soluble light polypeptide sequencesLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2014·Granted Mar 5, 2019·0 cites·11 claims
- 2453US10106619B2Virus vaccination and treatment methods with OX40 agonist compositionsCROFT MICHAEL·Filed 2007·Granted Oct 23, 2018·0 cites·16 claims
- 2551US2007116668A1Lymphotoxin-beta, lymphotoxin-beta Complexes, pharmaceutical preparations and therapeutic uses thereofBROWNING JEFFREY L·Filed 2005·Application pending·0 cites
- 2642US9694058B2Light-mediated anti-cell proliferative compositions and methodsWARE CARL F·Filed 2007·Granted Jul 4, 2017·0 cites·9 claims
- 2742US2012251505A1HUMAN LYMPHOID TISSUE INDUCER (LTi) CELL COMPOSITIONS AND METHODS OF USEWARE CARL F·Filed 2010·Application pending·0 cites
- 2841US2015266964A1Methods for accelerating immune regenerationUNIV MINNESOTA·Filed 2013·Application pending·0 cites
- 2940US2009311280A1Novel tnf receptor regulatory domainJOLLA INST ALLERGY IMMUNOLOG·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Carl F. Ware files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →